Anti-L1CAM radioimmunotherapy is more effective with the radiolanthanide terbium-161 compared to lutetium-177 in an ovarian cancer model

标题
Anti-L1CAM radioimmunotherapy is more effective with the radiolanthanide terbium-161 compared to lutetium-177 in an ovarian cancer model
作者
关键词
<sup>161</sup>Tb, <sup>177</sup>Lu, Radioimmunotherapy, Ovarian carcinoma, L1CAM, mAb chCE7
出版物
出版商
Springer Nature
发表日期
2014-05-23
DOI
10.1007/s00259-014-2798-3

向作者/读者发起求助以获取更多资源

Reprint

联系作者

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started